ProQR Therapeutics N.V.
(NASDAQ : PRQR)

( )
PRQR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.03%183.551.1%$846.87m
GILDGilead Sciences, Inc.
-1.04%80.700.9%$816.69m
CELGCelgene Corporation
-0.92%95.261.2%$791.42m
JUNOJuno Therapeutics, Inc.
-0.41%85.1013.5%$584.15m
BIIBBiogen Inc.
-2.51%291.871.2%$500.99m
REGNRegeneron Pharmaceuticals, Inc.
-0.31%332.152.7%$399.78m
VRTXVertex Pharmaceuticals Incorporated
-0.14%160.721.9%$358.41m
ALXNAlexion Pharmaceuticals, Inc.
-1.83%120.472.0%$256.63m
NKTRNektar Therapeutics
1.57%83.436.0%$246.17m
ILMNIllumina, Inc.
0.03%229.203.5%$234.08m
BLUEBluebird Bio, Inc.
2.25%213.3516.1%$201.76m
AAgilent Technologies, Inc.
-0.11%71.941.5%$173.78m
INCYIncyte Corporation
0.51%86.032.5%$158.32m
EXASExact Sciences Corporation
-0.57%48.8626.0%$132.16m
BMRNBioMarin Pharmaceutical Inc.
-0.16%84.984.4%$122.34m

Company Profile

ProQR Therapeutics NV operates as a biopharmaceutical company, which engages in the discovery and development of Ribonucleic Acid RNA based therapeutics for the treatment of genetic disorders. Its initial focus is on the development of a disease-modifying therapy for the treatment of cystic fibrosis. The company was founded by Daniel de Boer, Gerard Platenburg, Henri Termeer and Dinko Valerio on February 21, 2012 and is headquartered in Leiden, the Netherlands.